Overview of recent advances in metastatic triple negative breast cancer

Metastatic triple negative breast cancer (TNBC) has an aggressive phenotype with a predilection for visceral organs and brain. Best responses to chemotherapy are predominately in the first line. Recent studies have demonstrated improved progression free survival with the combination of atezolizumab/...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Reilly, David, Sendi, Maha Al, Kelly, Catherine M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968109/
https://www.ncbi.nlm.nih.gov/pubmed/33767972
http://dx.doi.org/10.5306/wjco.v12.i3.164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968109/
https://www.ncbi.nlm.nih.gov/pubmed/33767972
http://dx.doi.org/10.5306/wjco.v12.i3.164

Ejemplares similares